Skip to main content

scPharmaceuticals Inc.

SCPHDelisted Oct 7, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001604950

scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.

Q1 2025 vs. Q4 2024

How the institutions holding scPharmaceuticals Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of SCPH: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders86188+3
Shares39.8M90.5K37.5M−2.14M (−5.4%)
Value$140.8M$320.4K$98.7M−$41.7M (−29.7%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held scPharmaceuticals Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to SCPH in Q1 2025
InstitutionSharesValue% of portfolio
Velan Capital Investment Management LP917,668$2.41M2.48%
Nuveen, LLC90,503$238.0K0.00%
Marshall Wace, LLP73,210$192.5K0.00%
Citadel Advisors LLC38,663$101.7K0.00%
Cubist Systematic Strategies, LLC28,759$75.6K0.00%
Lido Advisors, LLC24,000$63.1K0.00%
Assenagon Asset Management S.A.12,430$32.7K0.00%
Chicago Partners Investment Group LLC12,728$30.7K0.00%
Manufacturers Life Insurance Company, The11,004$28.9K0.00%
Huntington National Bank711$1.87K0.00%
Russell Investments Group, Ltd.321$8440.00%
True Wealth Design, LLC32$850.00%

Sold out (9)

Institutions that held scPharmaceuticals Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of SCPH in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Suvretta Capital Management, LLC1,840,891$6.52M
Woodline Partners LP297,800$1.05M
Jane Street Group, LLC33,009$116.9K
XTX Topco Ltd27,531$97.5K
Sandy Cove Advisors, LLC10,592$37.5K
R Squared Ltd3,492$12.4K
BFSG, LLC1,500$5.31K
Caitong International Asset Management Co., Ltd267$945
IFP Advisors, Inc0$81

Not filed for Q1 2025 yet (1)

Institutions that held scPharmaceuticals Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SCPH in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC90,503$320.4K